"Deal makers were working from the beach as the IPO heat wave continued in July with 61 non-SPAC offerings raising ~$16 billion*. SPAC IPOs continued to normalize with 30 SPACs raising ~$5.7 billion*. Public debuts via De-SPACs were robust, with 29 SPACs completing their business combination ringing the bells at the NYSE & Nasdaq exchanges."
Craig Clay, President, Donnelley Financial Solutions
Congratulations to the 91 issuers who made their public debut in July via an IPO raising $22 billion* including our clients:
- Black Spade Acquisition
- Blend Lab
- Blue Foundry Bancorp
- Bridge Investment Group Holdings
- Candel Therapeutics
- Caribou Biosciences
- Core & Main
- Couchbase
- CS Disco
- Cytek Biosciences
- DA32 Life Science Tech Acquisition
- Dole
- Erasca
- F45 Training
- Gambling.Com
- Good Works II Acquisition
- HCW Biologics
- Icosavax
- Imago BioSciences
- Instructure
- Membership Collective Group
- MeridianLink
- Nuvalent
- Omega Therapeutics
- PowerSchool
- Paycor HCM
- Rallybio
- Rani Therapeutics
- RxSight
- Ryan Specialty Group
- Sight Sciences
- Sophia Genetics
- Stevanato Group
- Tenaya Therapeutics
- Traeger
- TScan Therapeutics
- VTEX
- Xponential Fitness
- Zevia